Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Study: New Engineered Particles Train the Body to Accept Allergens

FDA Delays Approval of Aquestive’s Anaphylm™ Sublingual Epinephrine Film

Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for Food Allergy Treatments

Beyond Desensitization: How PRT120 Rewires the Immune System for Peanut Allergy Remission

Will the Viaskin “Patch” Therapy for Peanut Allergy be Approved Soon?...

Aquestive Files IND to Begin Clinical Trials of Sublingual Epinephrine

Intra-Nasal Epinephrine Takes Step Forward After Three Positive Pre-Clinical Studies

FDA Approves Dupixent® as First Biologic for Treatment of Children Aged...

Allerdent Enables Patients to Maintain Seasonal Allergy Immunotherapy During COVID-19 Pandemic

Oral Immunotherapy: What You Should Know, and What’s New (Webinar)

Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped

BlueWillow Completes Preclinical Studies of Intranasal Peanut Allergy Vaccine

FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...

ARS to Present Data from Intranasal Epinephrine (ARS-1) Studies at AAAAI...

Your School On Our Map

Put Your School on the Map